A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult Participants
Clinical trial NCT07570147 · RECRUITING
Trial details
- NCT number
- NCT07570147
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2027-04-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.